Status:
TERMINATED
Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates
Lead Sponsor:
University of Connecticut
Collaborating Sponsors:
Janssen Pharmaceutica N.V., Belgium
Conditions:
Psychosis
Aggression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression...
Eligibility Criteria
Inclusion
- age 18 or over, psychotic disorder diagnosed on SCID, inmate at correctional facility for at least 2 weeks -
Exclusion
- active withdrawal from substances of abuse, non-psychotic individuals, pregnant women, people unable to give informed consent, patients on mood stabilizers
- \-
Key Trial Info
Start Date :
July 1 2002
Trial Type :
INTERVENTIONAL
End Date :
April 1 2004
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00203775
Start Date
July 1 2002
End Date
April 1 2004
Last Update
October 13 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of connecticut health center
Farmington, Connecticut, United States, 06030